Brigham Young University Names Intermountain’s Dustin Matsumori to Key Leadership Role for Its New Medical School
Intermountain Health will broaden its relationship with Brigham Young University thanks to an opportunity for Dustin Matsumori, vice president of Corporate Development.
BYU has appointed Dustin as its managing director of Medical School Planning. He will work directly with University President C. Shane Reese, as well as BYU’s executive leadership, to plan, develop, and establish the future BYU Medical School. The university shared its plans to create the school in July. Dustin’s designation also follows the appointment of Dr. Mark Ott, an accomplished and pioneering oncologist and surgeon at Intermountain hospitals and a legacy physician leader, as the medical school’s first dean.
Both leaders will have an exponential impact on BYU. Dustin’s mission-critical role will include leading and coordinating the work of consultants, subject matter experts, and working groups, including accreditation, clinical partnerships, curriculum, research, organizational design, construction, and more.
Dustin first joined Intermountain Health in 2012 as our director of Financial Planning. From there, he has held pivotal roles as the director of Capital Markets and Growth, vice president of Market Intelligence and Planning, and most recently, as vice president of Corporate Development. Some of his landmark work includes working with internal and external deal teams to structure over $2.2 billion in bonds to finance Intermountain’s major capital projects and completing Intermountain’s merger with SCL Health.
“This is a ‘once-in-a-lifetime’ opportunity and ‘full-circle’ moment for me,” Dustin said. “Like so many people, Intermountain Health has played a very important role in my life. I was born prematurely with hydrocephalus and an underdeveloped heart and lungs. I spent much of my life as a child and youth being cared for by our amazing caregivers at Primary Children’s Hospital. I’ve been fortunate to work with, and for, Intermountain, and I’m honored to now have the privilege to help BYU create a medical school that will train future generations of physicians who, in turn, will care for individuals and families both locally and internationally.”
Before joining Intermountain Health, Dustin held roles at J.P. Morgan and George K. Baum & Company. Intermountain was a client of both firms. He earned an MBA from BYU’s Marriott School of Business and a bachelor’s degree from Stanford University.
Dustin's impressive depth and breadth of expertise in healthcare, market intelligence, strategic planning, investment banking, project management, and corporate development will greatly benefit the university as it establishes its new medical school. “Dustin’s intelligence, expertise, work ethic, and integrity have been invaluable at Intermountain as he’s worked tirelessly across the enterprise,” said Dan Liljenquist, chief strategy officer. “I know he’ll do the same for BYU.”
“I’m thrilled that Intermountain Health is partnering in such an integral way in the development of BYU’s new medical school,” said Intermountain President and CEO Rob Allen. “Dustin’s impact on our organization has been tremendous and transformative, positioning Intermountain to advance its mission for generations to come. I invite caregivers across the enterprise to join me in congratulating Dustin on his appointment and celebrating our partnership with BYU on planning for their medical school’s success.”
Dustin’s work is likely to directly impact the looming physician shortage that’s starting to grip hospitals and clinics throughout the U.S. According to the American Medical Association, the physician deficit could reach as many as 124,000 doctors by 2034. In addition to helping reduce the size of that staffing shortage, BYU will also train physicians to serve in other nations, amplifying Dustin’s efforts for generations to come.